In a significant departure from decades of established medical consensus, researchers at the University of Kentucky have identified a novel…
Read More
DEA targets synthetic kratom-related products mitragynine pseudoindoxyl, MGM-15, and MGM-16 for temporary controls in Schedule I
In a decisive regulatory move aimed at curbing the proliferation of high-potency, synthetic psychoactive substances, the U.S. Drug Enforcement Administration…
Read More
DEA targets synthetic kratom-related products mitragynine pseudoindoxyl, MGM-15, and MGM-16 for temporary controls in Schedule I
In a decisive move to address the burgeoning public health risks associated with the proliferation of synthetic, highly potent derivatives…
Read More
The MIND Diet May Slow Age-Related Brain Atrophy and Cognitive Decline According to Recent Long-Term Study
Emerging research published in the Journal of Neurology, Neurosurgery & Psychiatry suggests that a specific dietary regimen—the Mediterranean-DASH Intervention for…
Read More
Unlocking the Molecular Clock: Duke-NUS Researchers Discover Protein Balance Critical to Combating Age-Related Muscle Loss and Cachexia
As life expectancies climb globally, public health systems face an unprecedented demographic shift. Populations are aging rapidly, and with this…
Read MoreDEA targets synthetic kratom-related products mitragynine pseudoindoxyl, MGM-15, and MGM-16 for temporary controls in Schedule I
The United States Drug Enforcement Administration (DEA) has initiated a significant regulatory crackdown on a burgeoning class of semi-synthetic alkaloids…
Read More
Breast cancers that disseminate to bone marrow acquire aggressive phenotypes through CX43-related tumor-stroma tunnels
Groundbreaking collaborative research from the University of Michigan and the University of California San Diego has uncovered a critical biological…
Read More
Unlocking the Bone Marrow Microenvironment: How Chronic Inflammation Fuels Pre-Leukemic States and Age-Related Blood Cancers
Every second of every day, the human bone marrow serves as a tireless biological factory, generating millions of fresh blood…
Read More
DEA targets synthetic kratom-related products mitragynine pseudoindoxyl, MGM-15, and MGM-16 for temporary controls in Schedule I
The United States Drug Enforcement Administration (DEA) has initiated a significant regulatory crackdown on a burgeoning class of synthetic alkaloids…
Read More
DEA targets synthetic kratom-related products mitragynine pseudoindoxyl, MGM-15, and MGM-16 for temporary controls in Schedule I
The United States Drug Enforcement Administration (DEA) has officially moved to curtail the proliferation of highly potent, synthetic derivatives associated…
Read More
